Quote
The world's major pharmaceutical companies joined forces with governments and leading global health organizations Monday to donate drugs and scientific know-how to help control or wipe out 10 neglected tropical diseases by 2020.
Drugmakers have been criticized in the past for not doing enough to fight diseases of the poor as they concentrate instead on conditions more prevalent in rich nations, such as high cholesterol.
But in the largest coordinated effort yet to fight diseases such as Guinea worm disease, leprosy and sleeping sickness, the group promised to give away 14 billion doses of medicines by the end of this decade.
They will also share expertise and drug discovery work to invent new medicines for neglected tropical diseases (NTDs) that as yet have no treatments.
Drugmakers have been criticized in the past for not doing enough to fight diseases of the poor as they concentrate instead on conditions more prevalent in rich nations, such as high cholesterol.
But in the largest coordinated effort yet to fight diseases such as Guinea worm disease, leprosy and sleeping sickness, the group promised to give away 14 billion doses of medicines by the end of this decade.
They will also share expertise and drug discovery work to invent new medicines for neglected tropical diseases (NTDs) that as yet have no treatments.
I'll be the first to accuse myself of being cynical, but when I read something like this:
- Am I really supposed to believe that any company will incur a voluntary out-of-pocket expense?
- Do these companies get shareholder approval for such donations?
- Do they turn around to their shareholders and tell them, sorry, profits will be down slightly for the next decade while we engage in this donation program over in Africa?
- Do they tell employees that raises will be slightly less over the next ten years due to their give-away program?
- Or do they increase the costs of their products to be paid by insurance companies and patients?
So, who's really doing the "giving" here, and is it "voluntary"? Big Pharma is joining forces with governments, so there's taxpayers' money right there. And I can't see but Big Pharma (company, shareholders, or employees) will not incur any loss due to their "donation" program, so that leaves their paying customers to foot the bill.
Have I made a lot of sense here, or am I being too critical?

Help
Sign In »
Register Now!


MultiQuote











